Literature DB >> 13201849

The blood-clotting mechanism during normal parturition.

O D RATNOFF, J E COLOPY, J A PRITCHARD.   

Abstract

Keywords:  BLOOD COAGULATION; LABOR/blood in

Mesh:

Year:  1954        PMID: 13201849

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  9 in total

1.  A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma.

Authors:  O D RATNOFF; J E COLOPY
Journal:  J Clin Invest       Date:  1955-04       Impact factor: 14.808

2.  A laboratory study of the carrier state in classic hemophilia.

Authors:  A MARGOLIUS; O D RATNOFF
Journal:  J Clin Invest       Date:  1956-11       Impact factor: 14.808

3.  Platelet counts during normal pregnancy.

Authors:  S A Sejeny; R D Eastham; S R Baker
Journal:  J Clin Pathol       Date:  1975-10       Impact factor: 3.411

4.  Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.

Authors:  D Ogston; C M Ogston; O D Ratnoff; C D Forbes
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

Review 5.  Blood clotting abnormalitis in relation to pre-eclampsia: a review.

Authors:  A T Coopland
Journal:  Can Med Assoc J       Date:  1969-01-18       Impact factor: 8.262

6.  Coagulation and fibrinolytic mechanisms during and after normal childbirth.

Authors:  J Bonnar; G P McNicol; A S Douglas
Journal:  Br Med J       Date:  1970-04-25

7.  [A study of clotting factors under labor. II. Factor XI, glas-contact-activation test, consumption of prothrombin. Inhibitor of tissue thromboplastin, thrombocytes].

Authors:  W W Stein; E Halberstadt; L Wüst; H J Rothe
Journal:  Arch Gynakol       Date:  1970

8.  Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.

Authors:  E D Crum; J R Shainoff; R C Graham; O D Ratnoff
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

9.  The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.

Authors:  O D Ratnoff; J Pensky; D Ogston; G B Naff
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.